Abstract:Background: Sorting nexin 10 (SNX10) has recently been identified as a critical regulator of colorectal carcinogenesis, whose deletion promoted cell proliferation and survival in human CRC cells, and promoted colorectal tumor growth and upregulated amino-acid metabolism in mice. However, what happens when silencing SNX10 in normal human intestinal epithelial cells (IECs) remains unknown, and no drugs targeting SNX10 have been reported. Here, we first investigated the biological function and underlying mechanisms of SNX10 in normal human IECs, and found that α-hederin, a pentacyclic triterpenoid saponin, has a regulatory effect on SNX10 expression. Purpose: This study aimed to explore the function of SNX10 in IECs to provide a new target for the prevention and treatment of malignant transformation and the intervention mechanism of α-hederin for further development of potential novel agents targeting SNX10. Methods: The transfection approach was used to construct SNX10 stable knockdown cells. Cell proliferation was detected by CCK8, clone formation, EdU, flow cytometry, and wound healing assays. Enzyme activity assays for glucose metabolism, qRT-PCR, western blotting, and immunofluorescence staining were performed to investigate the protein expression of signaling pathways. Results: Silencing SNX10 promoted cell proliferation and cycle transition in IECs and increased the activity of key enzymes involved in glucose metabolism. Moreover, DEPDC5 expression was significantly decreased following SNX10 knockdown, followed by activation of the mTORC1 pathway. α-hederin reversed the accelerated cell proliferation, cycle progression, and glucose metabolic activity, as well as the activated mTORC1 pathway caused by SNX10 knockdown, by notably increasing SNX10 expression in a dose-dependent manner. Conclusion: We first reported that knockdown of SNX10 in normal human IECs promoted cell proliferation and activated glucose metabolism by activating the mTORC1 pathway. Meanwhile, we first found that α-hederin down-regulated glucose metabolism activity and slowed cell proliferation by increasing SNX10 expression in IECs.

Inhibiting sorting nexin 10 promotes mucosal healing through SREBP2-mediated stemness restoration of intestinal stem cells

Sirtuin 1 Alleviates Endoplasmic Reticulum Stress-Mediated Apoptosis of Intestinal Epithelial Cells in Ulcerative Colitis.

SNX10‐mediated LPS Sensing Causes Intestinal Barrier Dysfunction Via a Caspase‐5‐dependent Signaling Cascade

Targeting sorting nexin 10 improves mouse colitis via inhibiting PIKfyve-mediated TBK1/c-Rel signaling activation

Differential analysis of sorting nexin 10 and sterol regulatory element–binding protein 2 expression in inflammatory bowel disease

SIRT1 Stabilizes β-TrCP1 to Inhibit Snail1 Expression in Maintaining Intestinal Epithelial Integrity to Alleviate Colitis

Sorting Nexin 10 Acting As a Novel Regulator of Macrophage Polarization Mediates Inflammatory Response in Experimental Mouse Colitis

Smad nuclear interacting protein 1 (SNIP1) inhibits intestinal inflammation through regulation of epithelial barrier function

α-hederin regulates glucose metabolism in intestinal epithelial cells by increasing SNX10 expression

Oral Nanoparticles of SNX10-shRNA Plasmids Ameliorate Mouse Colitis

Inhibition of Soluble Stem Cell Factor Promotes Intestinal Mucosal Repair

MAP3K2-regulated intestinal stromal cells define a distinct stem cell niche

Sorting Nexin 10 Acts As a Tumor Suppressor in Tumorigenesis and Progression of Colorectal Cancer Through Regulating Chaperone Mediated Autophagy Degradation of P21cip1/waf1.

SNX10 (sorting Nexin 10) Inhibits Colorectal Cancer Initiation and Progression by Controlling Autophagic Degradation of SRC.

DHX9 maintains epithelial homeostasis by restraining R-loop-mediated genomic instability in intestinal stem cells

Map3k2 -Regulated Intestinal Stromal Cells (MRISC) Define a Distinct Sub-cryptic Stem Cell Niche for Damage Induced Wnt Agonist R-spondin1 Production

Human Amniotic Epithelial Stem Cells Promote Colonic Recovery in Experimental Colitis via Exosomal MiR-23a-TNFR1-NF-κB Signaling

The Regeneration of Intestinal Stem Cells is Driven by Mir-29-induced Metabolic Reprogramming

Intestinal Stem Cells and Immune Cell Relationships: Potential Therapeutic Targets for Inflammatory Bowel Diseases

Integrin CD11b Attenuates Colitis by Strengthening Src-Akt Pathway to Polarize Anti-Inflammatory IL-10 Expression

Endothelial FOXC1 and FOXC2 promote intestinal regeneration after ischemia-reperfusion injury